This substantial stability of the nanocoating layers may be important for more predictable release of insulin (with the absence of unpredictable hypoglycemia) after oral administration than was the case with the insulin-chitosan alone, which we demonstrated in this study (Figure 5). This evidence concerns the gene INS and Hypoglycemia.